| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.085 | 0.004 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.02 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |